|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-3-18
|
|
pubmed:abstractText |
Conference abstracts of phase I trials (P1T) communicate important anticancer drug development information. Our objectives were to determine elements essential for good P1T abstract reporting, to assess the quality of P1T abstracts submitted to American Society of Clinical Oncology (ASCO) meetings, and to propose reporting guidelines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1782-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18347180-Abstracting and Indexing as Topic,
pubmed-meshheading:18347180-Adult,
pubmed-meshheading:18347180-Clinical Trials, Phase I as Topic,
pubmed-meshheading:18347180-Female,
pubmed-meshheading:18347180-Guidelines as Topic,
pubmed-meshheading:18347180-Humans,
pubmed-meshheading:18347180-Male,
pubmed-meshheading:18347180-Middle Aged,
pubmed-meshheading:18347180-Neoplasms,
pubmed-meshheading:18347180-Professional Competence,
pubmed-meshheading:18347180-Publication Bias,
pubmed-meshheading:18347180-Publishing,
pubmed-meshheading:18347180-Quality Control,
pubmed-meshheading:18347180-Research Design,
pubmed-meshheading:18347180-Retrospective Studies,
pubmed-meshheading:18347180-Societies, Medical
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Improving the quality of abstract reporting for phase I cancer trials.
|
|
pubmed:affiliation |
Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
